首页> 美国卫生研究院文献>Springer Open Choice >miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma
【2h】

miR-429 inhibits cells growth and invasion and regulates EMT-related marker genes by targeting Onecut2 in colorectal carcinoma

机译:miR-429通过靶向结直肠癌中的Onecut2抑制细胞生长和侵袭并调节EMT相关标记基因

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The 5-year survival rate for colorectal cancer is approximately 55 % because of its invasion and metastasis. The epithelial–mesenchymal transition (EMT) is one of the well-defined processes during the invasion and distant metastasis of primary epithelial tumors. miR-429, a member of the miR-200 family of microRNAs, was previously shown to inhibit the expression of transcriptional repressors ZEB1/delta EF1 and SIP1/ZEB2, and regulate EMT. In this study, we showed that miR-429 was significantly downregulated in colorectal carcinoma (CRC) tissues and cell lines. We found that miR-429 inhibited the proliferation and growth of CRC cells in vitro and in vivo, suggesting that miR-429 could play a role in CRC tumorigenesis. We also showed that downregulation of miR-429 may contribute to carcinogenesis and the initiation of EMT of CRC by targeting Onecut2. Further researches indicated that miR-429 inhibited the cells migration and invasion and reversed TGF-β-induced EMT changes in SW620 and SW480 cells. miR-429 could reverse the change of EMT-related markers genes induced by TGF-β1, such as E-cadherin, CTNNA1, CTNNB1, TFN, CD44, MMP2, Vimentin, Slug, Snail, and ZEB2 by targeting Onecut2. Taken together, our data showed that transcript factor Onecut2 is involved in the EMT, migration and invasion of CRC cells; miR-429 inhibits the initiation of EMT and regulated expression of EMT-related markers by targeting Onecut2; and miR-429 or Onecut2 is the important therapy target for CRC. Electronic supplementary materialThe online version of this article (doi:10.1007/s11010-013-1950-x) contains supplementary material, which is available to authorized users.
机译:由于其浸润和转移,大肠癌的5年生存率约为55%。上皮-间质转化(EMT)是原发性上皮肿瘤浸润和远处转移过程中的明确过程之一。先前显示,miR-200家族microRNA的成员miR-429抑制转录阻遏物ZEB1 /δEF1和SIP1 / ZEB2的表达,并调节EMT。在这项研究中,我们显示miR-429在结直肠癌(CRC)组织和细胞系中显着下调。我们发现miR-429在体外和体内均能抑制CRC细胞的增殖和生长,这表明miR-429可能在CRC肿瘤发生中起作用。我们还显示,miR-429的下调可能通过靶向Onecut2促进癌变和CRC的EMT启动。进一步的研究表明,miR-429抑制SW620和SW480细胞中的细胞迁移和侵袭并逆转TGF-β诱导的EMT变化。 miR-429可以通过靶向Onecut2来逆转TGF-β1诱导的EMT相关标记基因的变化,例如E-钙粘蛋白,CTNNA1,CTNNB1,TFN,CD44,MMP2,波形蛋白,Slug,Snail和ZEB2。两者合计,我们的数据显示转录因子Onecut2参与EMT,CRC细胞的迁移和侵袭。 miR-429通过靶向Onecut2抑制EMT的启动和EMT相关标记的调控表达; miR-429或Onecut2是CRC的重要治疗靶标。电子补充材料本文的在线版本(doi:10.1007 / s11010-013-1950-x)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号